文献速递肿瘤 PET/CT

监测性FDG PET/CT检测食管癌根治后复发的诊断价值

Diagnostic value of surveillance 18F-fluorodeoxyglucose PET/CT for detecting recurrent esophageal carcinoma after curative treatment.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2019-06-20

本研究回顾性分析375例食管癌根治后患者的782次监测性FDG PET/CT,在无临床复发指征时检测复发。PET/CT诊断复发敏感度100%(64/64)、特异度94.0%(675/718),并检出7例意外第二原发癌。监测性FDG PET/CT有助于发现早期复发或临床未疑及的早期第二原发癌。

要点

  • 无临床复发指征时,监测性FDG PET/CT检测食管癌复发的敏感度100%、特异度94.0%。
  • PET/CT诊断性能在不同初始分期及距根治治疗时间间无显著差异。
  • FDG PET/CT额外检出7例意外第二原发癌。

核心结论

  • 监测性FDG PET/CT是无临床复发疑似的食管癌根治后患者检测早期复发或临床未疑及早期第二原发癌的有用影像工具。

研究设计与样本

  • 回顾性分析375例食管癌根治后患者的782次连续FDG PET/CT监测研究。
  • 复发由扫描后2个月内病理确认或其他临床证据判定;扫描后至少6个月无临床复发证据视为真阴性。

主要发现

  • PET/CT检测复发的敏感度为100%(64/64),特异度为94.0%(675/718)。
  • PET/CT诊断性能在不同初始分期或PET/CT与根治治疗间隔时间之间无显著差异。
  • FDG PET/CT在7例患者中检出意外第二原发癌。

临床怎么用

  • 对食管癌根治后无临床复发指征的患者,可考虑将FDG PET/CT作为监测手段以发现早期复发或第二原发癌。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Esophageal carcinoma recurs within two years in approximately half of patients who receive curative treatment and is associated with poor survival. While 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) is a reliable method of detecting recurrent esophageal carcinoma, in most previous studies FDG PET/CT scans were performed when recurrence was suspected. The aim of this study was to evaluate FDG PET/CT as a surveillance modality to detect recurrence of esophageal carcinoma after curative treatment where clinical indications of recurrent disease are absent. METHODS: A total of 782 consecutive FDG PET/CT studies from 375 patients with esophageal carcinoma after definitive treatment were reviewed. Abnormal lesions suggestive of recurrence on PET/CT scans were then evaluated. Recurrence was determined by pathologic confirmation or other clinical evidence within two months of the scan. If no clinical evidence for recurrence was found at least 6 months after the scan, the case was considered a true negative for recurrence. RESULTS: The diagnostic sensitivity and specificity of PET/CT for detecting recurrent esophageal carcinomas were 100% (64/64) and 94.0% (675/718), respectively. There were no significant differences in the diagnostic performance of PET/CT for detecting recurrence according to initial stage or time between PET/CT and curative treatments. Unexpected second primary cancers were detected by FDG PET/CT in seven patients. CONCLUSIONS: Surveillance FDG PET/CT is a useful imaging tool for detection of early recurrence or clinically unsuspected early second primary cancer in patients with curatively treated esophageal carcinoma but without clinical suspicion of recurrence.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Kim SJ, Hyun SH, Moon SH, et al. Diagnostic value of surveillance 18F-fluorodeoxyglucose PET/CT for detecting recurrent esophageal carcinoma after curative treatment. Eur J Nucl Med Mol Imaging. 2019. PMID: 31222387. doi:10.1007/s00259-019-04387-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。